Clinical Trial Update: Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma [NA]

View source ↗

Summary

Clinical trial about percutaneous ethanol injection for primary papillary thyroid microcarcinoma; the study was terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papillary Thyroid Cancer

Drugs mentioned

• Percutaneous Ethanol Injection (percutaneous ethanol injection)

Snippet

Sponsor: Yale University | Conditions: Papillary Thyroid Cancer | NA | Status: TERMINATED | Results posted: 2019-11-25